CytoSorbents Corporation

(CTSO) Trade

By |

Profile

CytoSorbents Corp is a critical care immunotherapy company. It investigates and commercializes its blood purification technology to reduce uncontrolled inflammation in hospitalized patients internationally with the goal of preventing and treating multiple organ failure in life-threatening illnesses and cardiac surgery. Its product portfolio consists of Cytosord, Contrastsorb, Vetresq, Hemodefend and Drugsorb. The company's intellectual property consists of composition of matter, materials, methods of production, systems incorporating the technology and multiple medical uses. It derives its revenue from product sales and grants.

Contact Information

Website: www.cytosorbents.com
Email: avogel@cytosorbents.com
Main Phone: +1 732 329-8885
Address: 7 Deer Park Drive
Address 2: Suite K
State: NJ
City / Town: Monmouth Junction
Country: USA
Postal Code: 08852

Issuer Information

Exchange: NSC
CEO: Phillip P. Chan
Employees: 117
NAICS: Medical Laboratories(621511)
$ 8.86 $ -0.06 (-0.67%)
Last Price 8.86 Change $ -0.06 Change % -0.67 Tick N/A
Bid 8.36 Bid Size 500.00 Ask 11.00 Ask Size 300.00
Open 9.05 High 9.05 Low 8.67 Prev Close 8.92
Last Trade Volume 167,100 52 Wk Hi 14.95 52 Wk Low 5.95
Market Cap 280.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 31,651,821.00 EPS (TTM) -0.50 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 26 55
Number of Buys 13 33
Number of Sells 13 22
Net Activity 24785 225628
Last 10 Buys Shares
Michael G. Bator 1,000
Eric R. Mortensen 1,000
Phillip P. Chan 1,000
Edward R. Jones 1,000
Edward R. Jones 1,000
Vincent Capponi 1,000
Phillip P. Chan 1,000
Kathleen P. Bloch 1,000
Phillip P. Chan 1,000
Kathleen P. Bloch 1,000
Last 10 Sell Shares
Vincent Capponi 1,000
Vincent Capponi 1,000
Vincent Capponi 1,000
Vincent Capponi 1,000
Kathleen P. Bloch 1,000
Vincent Capponi 1,000
Kathleen P. Bloch 1,000
Vincent Capponi 1,000
Vincent Capponi 1,000
Kathleen P. Bloch 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 14 14 14 14
Low Target Price Estimate 11 11 11 11
Mean Target Price Estimate 12.6 12.6 12.6 12.6
Standard Deviation 1.14 1.14 1.14 1.14
Date of Most Recent Estimate 05/23/18 05/23/18 05/23/18 05/23/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1